- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Boehringer Ingelheim
Total 2527 results
-
National Jewish HealthBoehringer IngelheimCompleted
-
University College, LondonBoehringer IngelheimCompletedOvarian Cancer | Fallopian Tube CancerUnited Kingdom
-
Hannover Medical SchoolBoehringer IngelheimTerminated
-
University College, LondonBoehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited Kingdom
-
Unity Health TorontoBoehringer IngelheimUnknownCardiovascular Disease | DiabetesCanada
-
AIO-Studien-gGmbHBoehringer IngelheimTerminatedNon-small-cell Lung Cancer With Somatic EGFR MutationsGermany
-
Massachusetts General HospitalBoehringer IngelheimCompletedAtrial FibrillationUnited States
-
Aktion Bronchialkarzinom e.V.Boehringer IngelheimCompleted
-
Boehringer IngelheimAstellas Pharma IncCompleted
-
German Breast GroupBoehringer IngelheimCompleted
-
Mayo ClinicPfizer; Boehringer IngelheimCompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Saint Francis CareBoehringer IngelheimCompleted
-
Boehringer IngelheimUniversitätsklinikum Kiel, Onkologisches ZentrumRecruitingColorectal Cancer | Pancreatic Ductal Adenocarcinoma | Non-Small-Cell Lung CarcinomaGermany
-
Amsterdam UMC, location VUmcBoehringer IngelheimRecruitingAdvanced Stage Non-small Cell Lung CancerNetherlands
-
Medical University of GrazBoehringer IngelheimRecruiting
-
University Hospital, Basel, SwitzerlandBoehringer IngelheimRecruitingPustular Psoriasis (PP)Germany, Italy, Singapore, Switzerland, Portugal, Turkey
-
Holdsworth House Medical PracticeBoehringer IngelheimRecruitingSilicosis | Pneumoconiosis Coal | AsbestosisAustralia
-
University Medical Center GroningenBoehringer IngelheimRecruiting
-
Mount Sinai Hospital, CanadaBoehringer IngelheimRecruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Korea, Republic of, China, Germany, Belgium, Australia, Singapore, Canada, Italy, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, United Kingdom, Mexico, Romania, Brazil, India, South Africa, Colombia
-
University of Maryland, BaltimoreBoehringer IngelheimCompleted
-
Intermountain Health Care, Inc.Boehringer IngelheimCompletedDementia | Cognition Disorders | Cerebral Ischemic EventsUnited States
-
Seoul St. Mary's HospitalBoehringer IngelheimActive, not recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Canada
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
AA SecordBoehringer IngelheimCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States
-
Lawson Health Research InstituteBoehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedHealthy | Diabetes Mellitus, Type 2United States
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany, Spain, United States, Canada, Taiwan, Korea, Republic of, Finland, Denmark, France, Japan, Philippines, Vietnam
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, France, Guatemala, Italy, Korea, Republic of, Mexico, Poland, Russian Federation
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Canada, Colombia, Czech Republic, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United...
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Canada, El Salvador, Germany, Italy, Portugal, Russian Federation, Spain, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
University of Wisconsin, MadisonBoehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Austria, Germany
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Mexico, Korea, Republic of, Germany, Poland, Taiwan, Spain, Greece, France, Czech Republic, Hungary
-
Boehringer IngelheimEli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine